Long-term Secukinumab Effective for Ankylosing Spondylitis Long-term Secukinumab Effective for Ankylosing Spondylitis

The long-term results are welcome news because about half of patients do not respond to TNF inhibitors, which are the only treatment currently available for ankylosing spondylitis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news